昆虫细胞表达流感HA假型Gag-VLP制剂的脱靶效应在限制流感后金黄色葡萄球菌感染中的作用
本研究评估了表达A/Puerto Rico/8/1934 (H1N1) HA的Tnms42昆虫细胞表达、BEI处理的Gag-VLP制剂在预防小鼠流感后金黄色葡萄球菌重叠感染中的脱靶效应。结果显示,匹配的抗血凝素免疫足以预防致死性继发细菌感染导致的发病和死亡,即使单次低抗原剂量50 ng HA/只也有效;但单独诱导抗血凝素免疫无助于抑制异源病毒复制及后续细菌感染。作者提示VLP疫苗具有免疫原性潜力,但抗HA免疫不应被视为对抗流感和流感后细菌感染的唯一预防方法。
要点
- 匹配的抗HA免疫可预防致死性继发细菌感染导致的发病和死亡。
- 单次低抗原剂量50 ng HA/只仍观察到该保护效果。
- 抗HA免疫不能抑制异源病毒复制及后续细菌感染。
核心结论
- 匹配的抗血凝素免疫足以预防致死性继发细菌感染引起的发病和死亡。
- 抗HA免疫不应被视为对抗流感和流感后细菌感染的唯一预防方法。
研究设计与样本
- 使用Tnms42昆虫细胞表达、BEI处理的Gag-VLP制剂,表达A/Puerto Rico/8/1934 (H1N1)的HA。
- 在小鼠中预先感染同源或异源H1N1病毒株后,评估该制剂预防金黄色葡萄球菌重叠感染的脱靶效应。
主要发现
- 匹配的抗血凝素免疫可预防致死性继发细菌感染导致的发病和死亡。
- 单次低抗原剂量50 ng HA/只仍观察到保护效果。
- 单独诱导抗血凝素免疫无助于抑制异源病毒复制及后续细菌感染。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical and historical data underscore the ability of influenza viruses to ally with Staphylococcus aureus and predispose the host for secondary bacterial pneumonia, which is a leading cause of influenza-associated mortality. This is fundamental because no vaccine for S. aureus is available and the number of antibiotic-resistant strains is alarmingly rising. Hence, this leaves influenza vaccination the only strategy to prevent postinfluenza staphylococcal infections. In the present work, we assessed the off-target effects of a Tnms42 insect cell-expressed BEI-treated Gag-VLP preparation expressing the HA of A/Puerto Rico/8/1934 (H1N1) in preventing S. aureus superinfection in mice pre-infected with a homologous or heterologous H1N1 viral challenge strain. Our results demonstrate that matched anti-hemagglutinin immunity elicited by a VLP preparation may suffice to prevent morbidity and mortality caused by lethal secondary bacterial infection. This effect was observed even when employing a single low antigen dose of 50 ng HA per animal. However, induction of anti-hemagglutinin immunity alone was not helpful in inhibiting heterologous viral replication and subsequent bacterial infection. Our results indicate the potential of the VLP vaccine approach in terms of immunogenicity but suggest that anti-HA immunity should not be considered as the sole preventive method for combatting influenza and postinfluenza bacterial infections.
引用
- Klausberger M, Leneva IA, Egorov A, et al. Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections. Vaccine. 2019. PMID: 31718898. doi:10.1016/j.vaccine.2019.10.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。